Negative regulation of peptidyl-tyrosine phosphorylation

pathway activity — cross-omics
GO:0050732Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of peptidyl-tyrosine phosphorylation pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SIGLEC14, CCL4L2, and CSF3R, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of peptidyl-tyrosine phosphorylation activity versus SIGLEC14 in GBM (Pearson r = 0.28).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMSIGLEC14 →+0.661+0.175.007.00234
UCECCCL4L2 →+0.722+0.291.006<.00134
HNSCCSF3R →+0.782+0.165<.001<.00134
HNSCNLRP3 →+0.932+0.168<.001.00534
HNSCFPR2 →+0.659+0.102.003.00634
HNSCFGR →+0.819+0.138<.001.00734
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0050732 vs SIGLEC14 — GBM

Per-sample scatter of Negative regulation of peptidyl-tyrosine phosphorylation activity vs SIGLEC14 in GBM.

Explore this scatter interactively →

Exploration